Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
Shijiazhuang Pharma's Vitamin B12 passed EU inspection2009-02-28
Jiuxin Pharma to found APIs base in Niaoning2009-02-26
SFDA issues  requirements on import drug re-registration2009-02-24
Luwei to expand capacity of Vitamin C to 30000 ton2009-06-29
Guangji Pharma resume the production of Riboflavin2009-02-19
China plans to carry out DMMF system2009-02-18
Guangji's β-Carotene project went smoothly2009-02-13
Zhejiang NHU to found Vitamin A palmitate unit2009-02-07
Nhwa Pharma's Gabapentin past German GMP certification2009-02-06
USA initiated 337 Investigation for Chinese Glucosamine Sulfate2009-02-05
Kaifeng Pharma's Cefpiramide project got government's fund2008-12-08
Sinovac's Subsidiary Obtains High-Tech Enterprise Status2009-03-10
Shijiazhuang Pharma's Vitamin B12 passed EU inspection2009-03-02
CSPC Sales Revenue hit over 10 Billion yuan in 20082009-02-27
Gooddoctor Pharma to found cGMP base of  finished drugs2009-02-23
Jiuxin Pharma to found APIs base in Niaoning2009-02-20
SFDA issues Guidelines on Protection of TCM2009-02-19
Export & Import statistics of western medicine in China in 20082009-02-17
32 pharmas into Top 200 Enterprises of Potential in China2009-02-17
Bayer Schering Pharma to open Beijing R&D center2009-02-16
China suspends use of an herbal injection after death reported2009-02-13
Genesis Pharma to purchase Hongrui Pharma2009-02-05
Some Artemisinin enterprises stopped production2009-02-04
SFDA issues relevant requirements on import drug re-registration2009-02-02
SFDA warned adverse reaction of cefradine2009-01-20
Hefei to found biggest Hepatitis B Vaccine base2009-01-16
Demand rebounds for APIs with big size2009-01-15
SFDA issues Requirements on Special Approval of New Drug Registration2009-01-14
Chinese Amlodipine tablet will enter EU2009-01-13
Daiichi Sankya seeks Chinese nod for silodosin2009-01-12
Tianyao's Methylprednisolone and Spironolactone passed COS authentication2009-01-09
SFDA stopped the poduction & sale of Fenfluramine HCL2009-01-08
4532个 页次:129/14232个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463